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New Conduits for Electrical Flow*Peter Kohl, MD, PHDC onventional wisdom suggests: this shouldnot be possible. You should not be able tosuccessfully restore sequential activation of
cardiac chambers in an adult animal with complete
atrioventricular conduction block simply by gluing
one end of a dish-grown tissue strand containing
neonatal rodent myocytes to the outer surface of the
atrium and the other end to the ventricle. However,
that is exactly what Cingolani et al. (1) report in this
issue of the Journal.SEE PAGE 2575The authors (1) reconﬁrm earlier work (2) showing
that myocardial tissue grafts can serve as conduits to
“patch up” electrical conduction. Their electrical
conduits are formed using paramagnetic beads with
surface-conjugated antibodies that bind either
neonatal cardiac myocytes or human stromal cells,
mixed in varying ratios and attracted by a linear
magnetic ﬁeld to form an elongated, structurally and
functionally integrated tissue strand. In vitro, these
conduits synchronize spontaneous electrical activity
of otherwise disconnected regions of cardiac neonatal
cell cultures, as shown earlier in similar cell culture
models for bridges containing cardiac myocytes (3) or
connexin-expressing nonmyocytes (4). In vivo, the*Editorials published in the Journal of the American College of Cardiology
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the contents of this paper to disclose.investigators attached the ends of preformed myo-
cyte/nonmyocyte strands to right atrial and right
ventricular epicardium, using ﬁbrin glue but no other
treatment of cardiac or conduit contact sites, which is
perhaps the most elegant and most surprising aspect
of their report. After 3 days, this procedure offered an
atrioventricular conduction pathway, which sup-
ported sequential chamber activation when the
intracardiac conduction system was taken out of ac-
tion by methacholine perfusion. They report abun-
dant connexin 43 expression at contact sites of native
and engineered tissue, compatible with electrical
connection via functional heterotypic cell coupling in
the heart (5).
The present report (1) builds on and reinforces
previous research, also conducted in rats, with
myogenic progenitor cell grafts surgically implanted
into the atrioventricular groove (2). These grafts
supported atrioventricular conduction in one-third of
animals, with the added beneﬁt that they became
vascularized over time, surviving for the animals’
lifetimes. In both studies, atrium–graft and graft–
ventricle electrical conduction had to cross disconti-
nuities in myocardial tissue, epicardium, or scars.
The principal possibility of passive cardiac action
potential propagation through non-excitable mesen-
chymal cells had been known from cell culture
studies for 45 years (6). Its presence was subse-
quently documented in patients with electrical
propagation across atrio-atrial (7) and atrioventric-
ular (8) lesions after cardiac surgery. The underlying
electrotonic coupling of heterotypic heart muscle and
mesenchymal cells, identiﬁed in vivo 10 years ago
(9), is an important, yet often overlooked, facet of
cardiac electrophysiological integration that deserves
further attention (for a recent update on this ﬁeld,
see [5]).
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2587Cardiac conduction pathway repair using engi-
neered biological conduits has signiﬁcant clinical
translation potential. Use of human pluripotent stem
cell–derived cardiomyocytes and ﬁbroblasts for
patient-speciﬁc electrical grafts is an obvious avenue.
This option would add signiﬁcantly to the current
range of cell injection–based approaches for cardiac
tissue repair (10), taking the ﬁeld from the delivery of
more locally acting agents to provision of targeted
long-distance pathways.
Technological developments to grow human
pluripotent stem cell–derived cardiomyocytes in
aligned tissue strands have begun (11), although
describing them as biowires understates their poten-
tial importance. Conduction in “wires” is passive and
characterized by progressive signal attenuation, as
would be observed with action potential propagation
through tissue constructs made entirely from non-
excitable cells. These would bridge relatively short
distances only (up to 300 mm in vitro [4]), and they
are likely to underlie coupling across the graft–
myocardium interface. The key advantage of having
cardiac myocytes as an integral component of a
conduit, even if they themselves were not to form a
continuous conductive chain, is that they act like
action potential “repeater stations” (12), sustaining
electrical signal ﬁdelity from input to output of the
graft.
Several hurdles must be overcome on the way to
clinical application. These include:
 Automaticity. The ideal electrical conduit will have
no or very low spontaneous excitation rates. This
can presumably be achieved by selecting suitable
cells for the graft.
 Connectivity. Grafts would ideally couple well at
their ends but remain insulated along much of
their progression. This pattern seems well sup-
ported by the approach presented by Cingolani
et al. (1); they used a ﬁxation technique that (in
contrast to surgical integration) evades excess
deposition of electrically insulating acellular con-
nective tissue at contact sites, whereas leaving the
intermediate conduit free from direct association
with the myocardium.
 Source–sink relations. Linked to connectivity and
directionality, it will be necessary to control input
and output loads at the atrial and ventricular ends
of the conduit. This may be achievable using
advanced tissue engineering.
 Directionality. Avoidance of retrograde conduction
may be attainable by controlling source–sink re-
lations and connexin coupling patterns at both
graft ends. This may beneﬁt from quantitativecomputational modeling to aid design of tissue
implants and their connections to the heart.
 Location. Relative ease of epicardial access should
be balanced with the advantages of endocardial
activation. For the proof of principle reported here,
the former was understandably an overriding
concern, but further research will be needed to
ascertain the best placement of conduits for uni-
ventricular or potentially biventricular “pacing.”
 Durability. Cingolani et al. (1) observed effective
atrioventricular coupling 3 days after conduit im-
plantation. During this period, an alternative
mechanistic explanation of atrioventricular syn-
chronization may apply (Figure 1).
 Stability (mechanical). Constructs, in particular if
attached mechanically only at their ends, must
withstand their own and the heart’s contraction, as
well as any hemodynamic and respiration-induced
changes in the relative topology of atrial and
ventricular attachment sites. This may be aided
by suitably balancing muscle and nonmuscle
construct constituents (as explored by the in-
vestigators) and by carefully scaling graft lengths
to attachment loci.
 Stability (metabolic). Electrical conduits in the
heart are likely to require vascularization, in
particular if the myocytes within them mature.
This at least is the message from trabeculae car-
neae, which, if larger than 4 to 8 myocytes per
cross-section (constructs used here exceed the
corresponding dimension by about an order of
magnitude), regularly have their own blood supply
with a capillary-to-myocyte ratio of w0.5 in the rat
(13).
 Stability (immunological). To prevent rejection,
the present study (1) explanted hearts for ex vivo
experiments after 3 days. This concern may be
avoided using individualized stem cell–derived
grafts and biodegradable structural support mate-
rials for the initial conduit generation.
In spite of this long list, the vision of being able to
patch up not only the plumbing of the heart using
autologous replacement vessels, but also its wiring
using individualized electrical conduits, is inspiring.
Of course, electrical rewiring will not solve all forms
of conduction block. Furthermore, adding an alter-
native activation pathway could be counterproduc-
tive, in particular for intermittent “functional”
disturbances. Additional studies, involving larger
numbers of animals and perhaps more traditional
atrioventricular block models, are needed to sys-
tematically address the concerns listed previously,
but an encouraging start has been made.
FIGURE 1 Atrioventricular Pacing in the Absence of
Electrical Coupling (Dog With Complete Atrioventricular
Conduction Block)
Formation of an atrial tissue sling to mechanically stimulate
ventricular myocardium gave rise to coordinated atrial and
ventricular beats, lasting 2 to 4 days, after which time
idioventricular rhythms resumed. I.V.C. ¼ inferior vena cava;
S.V.C. ¼ superior vena cava. Reprinted with permission from
Starzl et al. (14).
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2588Only the future can tell whether this vision will
materialize. Looking to lessons from the past, it is
instructive to revisit the work of Starzl et al. (14) who,
in 1963, tried to treat complete atrioventricular
conduction block in dogs by autologous sinoatrialnode transplantation into the right ventricle.
Although they saw no evidence of a change in idio-
ventricular rhythms after nodal transplant in any
animal (0 of 9), dogs in the control series were
effectively treated (2 of 2), if temporarily. In these
animals, an atrioventricular sling was constructed
(Figure 1) that afforded mechanically mediated atrio-
ventricular synchronization, whereby the atrial “tug”
triggered ventricular excitation. Pacing, on the basis
of mechanoelectric feedback (15), lasted 2 to 4 days,
at which time autopsy established that the atrial
sling had become attenuated, rendering mechanical
coupling ineffective. It would be interesting to
explore whether similar mechanisms may have
contributed to the 3-day observations reported here.
In conclusion, the paper by Cingolani et al. (1)
serves as a reminder that “convention” is not “wis-
dom” and that the most intriguing observations tend
to arise from venturing outside the box. Their study
certainly does that.
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